An anti-HIV drug containing at least one porphyrin derivative selected between the following groups (A) and (B) as the active ingredient: (A) porphyrins modified with compounds selected among carbodiimides, alkylenediamines and alcohols, and (B) complexes between plasma proteins or chemically modified plasma proteins and porphyrins which may be modified with compounds selected among carbodiimides, alkylenediamines and alcohols. The drug is useful for preventing and treating AIDS, because it is excellent in the activity of killing HIV-infected cells, inhibiting cell injury caused by HIV infection and inhibiting HIV replication, and is highly safe.
一种抗艾滋病毒药物,含有至少一种选自以下组别(A)和(B)的
卟啉衍
生物作为活性成 分:(A)用选自碳二
亚胺、烷基二胺和醇中的化合物修饰的
卟啉,以及(B)血浆蛋白或经
化学修饰的血浆蛋白与可能用选自碳二
亚胺、烷基二胺和醇中的化合物修饰的
卟啉之间 的复合物。这种药物在杀灭受 HIV 感染的细胞、抑制 HIV 感染引起的细胞损伤和抑制 HIV 复制等方面具有卓越的活性,而且安全性高,因此可用于预防和治疗艾滋病。